Bayer will consolidate in New Jersey
Bayer HealthCare has selected New Jersey as the place to consolidate its East-Coast business site.
"We are very excited about the prospect of having a new site and facility that can house East Coast-based Bayer HealthCare employees from every division and function under one roof," said Mark Trudeau, president and CEO, Bayer HealthCare Pharmaceuticals and chair of the company's U.S. East Coast Site Search Committee. "New Jersey is home to many biopharmaceutical and healthcare companies, and we look forward to benefiting from the many resources and opportunities available to us in the state."
Commenting on the company's decision, Governor Chris Christie said, "Bayer's commitment to stay and expand in New Jersey is another signal that our state is growing and that this administration's job creating policies are paying dividends. Bayer's planned investment in New Jersey will help keep us the premier state in the nation for the pharmaceutical industry in addition to creating needed jobs and giving a boost to our state's economy."
Although a specific location has not yet been chosen, several sites near the company's existing New Jersey locations are under consideration. Between its divisions and corporate functions the company employs approximately 2,500 people in the New Jersey and New York area.